Literature DB >> 18781928

Status of cytokines in ischemia reperfusion induced heart injury.

Ming Zhang1, Li Chen.   

Abstract

Extensive investigations have implicated cytokines such as tumour necrosis factor (TNF)- alpha and interleukin (IL)-1, and IL-6 as contributing to the pathology of ischemia-reperfusion (I/R) injury, since an increase in the production of those cytokines was clinically detected after myocardial infarction and cardiopulmonary bypass surgery. Current evidence indicates that these cytokines are autocrine contributors to myocardial dysfunction and cardiomyocyte necrosis in I/R injury, whereas, earlier evidence also suggest that cytokines have controversial roles in cardiovascular pathophysiology. Accordingly, it becomes vital to better define the mechanisms of action of cytokines as important steps towards the development of effective therapeutic strategies to combat their deleterious effects in ischemia-induced myocardial injury. Since TNF-alpha, TGF-beta1, IL-1, IL-6 and IL-8 have been frequently studied in cardiovascular diseases, especially in I/R heart disease, the purpose of this article is to review the cardiodepressant role of these cytokines and their release in I/R injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781928     DOI: 10.2174/187152908785849116

Source DB:  PubMed          Journal:  Cardiovasc Hematol Disord Drug Targets        ISSN: 1871-529X


  12 in total

1.  DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion.

Authors:  Hui-Chun Ku; Wen-Pin Chen; Ming-Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-12       Impact factor: 3.000

Review 2.  Chronicles of a death foretold: dual sequential cell death checkpoints in TNF signaling.

Authors:  Marie Anne O'Donnell; Adrian T Ting
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

3.  Extracorporeal membrane oxygenation induced cardiac dysfunction in newborn lambs.

Authors:  Lee A Pyles; Robert A Gustafson; James Fortney; Stanley Einzig
Journal:  J Cardiovasc Transl Res       Date:  2010-09-17       Impact factor: 4.132

4.  TM-1-1DP exerts protective effect against myocardial ischemia reperfusion injury via AKT-eNOS pathway.

Authors:  Hui-Chun Ku; Shih-Yi Lee; Chi-Hsuan Chen; Yao-Hsing Wang; Chin-Ting Lin; Shoei-Sheng Lee; Ting-Hsuan Li; Ming-Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-13       Impact factor: 3.000

Review 5.  Necroptosis: biochemical, physiological and pathological aspects.

Authors:  Zsuzsanna Dunai; Pal I Bauer; Rudolf Mihalik
Journal:  Pathol Oncol Res       Date:  2011-07-21       Impact factor: 2.874

6.  Sevoflurane alleviates myocardial ischemia/reperfusion injury via actitation of heat shock protein-70 in patients undergoing double valve replacement surgery.

Authors:  Yue Shan; Kai Xie; Qifu Zhou; Rui He; Zhonghua Chen; Weizhong Feng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 7.  Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.

Authors:  Pamela Lockyer; Jonathan C Schisler; Cam Patterson; Monte S Willis
Journal:  Mol Endocrinol       Date:  2009-12-16

8.  Cardiomyocyte ATP release through pannexin 1 aids in early fibroblast activation.

Authors:  Elena Dolmatova; Gaelle Spagnol; Daniela Boassa; Jennifer R Baum; Kimberly Keith; Cinzia Ambrosi; Maria I Kontaridis; Paul L Sorgen; Gina E Sosinsky; Heather S Duffy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

Review 9.  Going up in flames: necrotic cell injury and inflammatory diseases.

Authors:  Sreerupa Challa; Francis Ka-Ming Chan
Journal:  Cell Mol Life Sci       Date:  2010-06-08       Impact factor: 9.207

10.  Effect of venovenous extracorporeal membrane oxygenation on the heart in a healthy piglet model.

Authors:  Juanhong Shen; Wenkui Yu; Jialiang Shi; Qiyi Chen; Yimin Hu; Juanjuan Zhang; Tao Gao; Fengchan Xi; Jianfeng Gong; Changsheng He; Ning Li; Jieshou Li
Journal:  J Cardiothorac Surg       Date:  2013-06-28       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.